Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study. - Wikidata - wikimedia - TriplyDB

Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study.

Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study.

http://www.wikidata.org/entity/Q33958028

about

Terlipressin for hepatorenal syndrome Hepatorenal syndrome Acute Kidney Injury in Patients with Cirrhosis Renal failure in cirrhosis: Emerging concepts Creatinine Change on Vasoconstrictors as Mortality Surrogate in Hepatorenal Syndrome: Systematic Review & Meta-Analysis Acute-on-Chronic Liver Failure: Recent Concepts Protecting the Kidney in Liver Transplant Candidates: Practice-Based Recommendations From the American Society of Transplantation Liver and Intestine Community of Practice.Increased survival of cirrhotic patients with septic shock.Bile Cast Nephropathy in Patients with Acute Kidney Injury Due to Hepatorenal Syndrome: A Postmortem Kidney Biopsy Study Prevalence of renal dysfunction in patients with cirrhosis according to ADQI-IAC working party proposal.Current management of the complications of portal hypertension: variceal bleeding and ascites.Therapy insight: Management of hepatorenal syndrome.Pharmacology, clinical efficacy and safety of terlipressin in esophageal varices bleeding, septic shock and hepatorenal syndrome.The course of type 1 hepato-renal syndrome post liver transplantation.Therapeutic response to vasoconstrictors in hepatorenal syndrome parallels increase in mean arterial pressure: a pooled analysis of clinical trials.Renal impairment in cirrhosis unrelated to hepatorenal syndrome Albumin treatment regimen for type 1 hepatorenal syndrome: a dose-response meta-analysis.Revision and update on clinical practice guideline for liver cirrhosis.Reconsidering hepatorenal syndrome. Throw in the towel? Not so fast!Hepatorenal syndrome: the 8th International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group.Pathophysiological basis of pharmacotherapy in the hepatorenal syndrome.Terlipressin and albumin for type 1 hepatorenal syndrome: does bacterial infection affect the response?Meta-analysis: terlipressin therapy for the hepatorenal syndrome.Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis.Acute renal dysfunction in liver diseases A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome Recent advances in the management of hepato-renal syndrome (HRS).The management of renal failure in patients with liver disease. Experiences from a district general hospital.Acute kidney injury in cirrhosis.Management and treatment of patients with cirrhosis and portal hypertension: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program.Updates on Hepato-Renal Syndrome Treatment of hepatorenal syndrome.Poor outcomes with treatment of hepatorenal syndrome type 1 with splanchnic vasoconstrictors and albumin: report of seven cases and review of the literature.Clinical use of albumin in hepatology.Management of hepatorenal syndrome in patients with cirrhosis.Hepatorenal syndrome in the intensive care unit.A new look at renal dysfunction in the cirrhotic patient Optimal management of hepatorenal syndrome in patients with cirrhosis.The efficacy and safety profile of albumin administration for patients with cirrhosis at high risk of hepatorenal syndrome is dose dependent Emerging hepatic syndromes: pathophysiology, diagnosis and treatment.

P2860

Q24243962-B8E657F7-717E-4DA7-B4D5-E6FE08B6CD0E Q24682192-411955A9-F5E9-43C1-8885-854CDDFB4E0A Q26775643-7FE923A0-3906-40BA-9F54-88DAC89D7423 Q26785971-A6347C6B-87CB-40F0-859A-6F0612E9B4E7 Q26795734-3C0BF066-0DB4-422E-800D-D256A1B5BDB7 Q26823752-2AE7B616-9C8D-472D-BB4A-3866959ED007 Q30251763-C188922B-3DE6-4634-A421-36E2E14D846E Q33754347-A95A48C4-464C-4AA3-98F1-41820BF9761C Q33805260-1332887D-D84B-4B7A-95FC-56A405D777AB Q33905612-B78EFFE8-AAEC-44D4-8625-D245D934E6BB Q34523099-89889CDB-30E6-4127-A0BA-ED60BC0E0B1A Q34533221-ECE90DD4-477B-4EED-9315-EBCFDCC07882 Q34601701-73871BC4-D410-491D-8C6B-24A171F20B3C Q35160366-10F5E7FA-B27C-4A21-94FD-1B9E7E590C04 Q35654104-FA66A3C4-C1EC-48EB-AD5B-64EF42C8419C Q35742662-99F6EEA9-3CA6-4E3F-9913-C0079D03B075 Q35852815-BA6A8B02-0362-402F-9A35-D9D10DD977B5 Q35890613-DA3C66FE-E423-465B-854C-05DDD19321E1 Q35994071-65509AAC-F3EF-4467-9436-F9EC4202B50F Q36093575-8295B8C9-781A-443F-A35E-4B71547907CA Q36203618-E78901FA-24F1-4C14-AEA8-9B74A2022D37 Q36400103-FEBFB348-14C2-4D88-929F-E642404C8B22 Q36583826-0B1FD8F0-2BA1-43D8-B167-5CF32CEECFAA Q36772257-EB580680-68C8-4871-9938-B3B57F4FBF97 Q36975923-96504910-880E-4E38-9724-C269A86746DD Q37061659-6788969B-508F-4BDD-BA48-195B434B02D8 Q37088317-5E7B4AA9-506B-45D6-AC82-23431BFCC900 Q37141944-576647D7-A2C6-48CC-9E82-558DDEB4E067 Q37323711-AA08E5C3-6900-45A7-A922-A6BDE149C5AF Q37489472-338D01A2-5DFA-48F7-9CC6-762085A8601E Q37498513-7E398495-641E-4A99-8391-F03733A10582 Q37605883-7964D9DA-B56C-4F34-BBE7-D1BFF93DD851 Q37634026-A06949D6-E8A9-45D8-B60D-A2AE917EB49B Q37655017-79EAC210-5AAE-4BB4-9D2C-CCEC6674DB3B Q37913980-7CDDF0EE-910E-4EFB-B3D6-2E2230708739 Q37920945-0A9E38CA-0E73-4A58-B120-1F6B575D55BE Q37990116-DDB88B5F-6760-42A6-9959-C776C9E0840E Q38173738-B8AD36D8-EA85-451A-8FCD-ABE4AAA2B63D Q38547853-59D979DA-7265-42C6-A88E-766668197197 Q38858262-787E0FA5-E7FE-475A-9B40-EF4AEE873C4B

P2860

Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study.

http://www.wikidata.org/entity/Q33958028

description

2002 nî lūn-bûn

@nan

2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Terlipressin in patients with ...... trospective multicenter study.

@ast

Terlipressin in patients with ...... trospective multicenter study.

@en

type

label

Terlipressin in patients with ...... trospective multicenter study.

@ast

Terlipressin in patients with ...... trospective multicenter study.

@en

prefLabel

Terlipressin in patients with ...... trospective multicenter study.

@ast

Terlipressin in patients with ...... trospective multicenter study.

@en

P1433

Q33958028-3AAC3ED1-642F-4E01-87E2-EB50B2CB4528

P1476

Q33958028-688AD30F-4DB6-4F35-A160-0EF2CE8B16B7

P2093

Q33958028-0BBAA7F9-C4F6-432F-ACE5-E8AC7AC789F3

Q33958028-11249E63-4A55-49A1-9D1B-FA39A8694546

Q33958028-13F8E49A-8B39-4222-BC66-005D635F4774

Q33958028-1795891E-19B1-46FF-9FCC-DAFE0952F87A

Q33958028-1B09F51C-CF63-4B9F-ABC0-C5F0F94690B4

Q33958028-26F99125-A3A1-444E-94A5-85287A546E8D

Q33958028-2AA4FABC-C6A9-432C-86E8-673B4C28BF82

Q33958028-3020DD7B-48FB-4C8F-92C1-6203B424A729

Q33958028-33877322-C097-4B17-8994-D35DD9051EAD

Q33958028-3980175A-5CE6-4140-AB81-C33F0D2FA030

P304

Q33958028-88157DC6-5402-4810-B844-22F9A529EE77

P31

Q33958028-98FA70CE-659D-4558-BE9E-5A9CE17A4C8F

P356

Q33958028-E93B6CD7-D0F2-49F3-83FE-3A9C273D2227

P407

Q33958028-C9582284-2531-4094-B85D-76733790E567

P433

Q33958028-0B58D12B-07F8-4A18-87A8-257AD1FC7C3C

P478

Q33958028-25988958-4343-4A26-A649-25516ECF9203

P50

Q33958028-3CC1197C-6A97-4E97-B42B-C89DF07DC3CB

Q33958028-93D2AB4C-91AD-4271-9113-AEECC82D3D06

Q33958028-F3F49DD9-58BD-44C3-BB2C-D4EA635FE216

P577

Q33958028-19DAC300-DA2A-41E1-8714-872BB05D4AFA

P698

Q33958028-D111A7DD-B8BD-4C32-BDED-12438A978BD0

P921

Q33958028-1CCF081E-F469-4BB1-ABA0-2E36A0C7AA08

Q33958028-A5B4B9BF-3351-4D68-8873-8BC8C3E11000

P356

GAST.2002.32364

P1433

Gastroenterology

P1476

Terlipressin in patients with ...... trospective multicenter study.

@en

P2093

Alexandre Pariente

http://www.w3.org/2001/XMLSchema#string

Andrzej Platek

http://www.w3.org/2001/XMLSchema#string

Antoine Hadengue

http://www.w3.org/2001/XMLSchema#string

Armand Abergel

http://www.w3.org/2001/XMLSchema#string

Brigitte Bernard

http://www.w3.org/2001/XMLSchema#string

Cathy Fleurot

http://www.w3.org/2001/XMLSchema#string

Chantal Halimi

http://www.w3.org/2001/XMLSchema#string

Christian Duhamel

http://www.w3.org/2001/XMLSchema#string

Danielle Gurnot

http://www.w3.org/2001/XMLSchema#string

Didier Lebrec

http://www.w3.org/2001/XMLSchema#string

P304

923-930

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/GAST.2002.32364

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

122

http://www.w3.org/2001/XMLSchema#string

P50

Dominique C Valla

Thierry Poynard

Francois Durand

P577

2002-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11910344

http://www.w3.org/2001/XMLSchema#string

P921

liver cirrhosis

multicenter trial